ArticleOncotarget2016

In vivo phage display screening for tumor vascular targets in glioblastoma identifies a llama nanobody against dynactin-1-p150Glued.

Sanne A M van Lith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.